{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T06:59:15Z","timestamp":1774767555052,"version":"3.50.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005052","name":"Nano Mission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001427","name":"All India Council for Technical Education","doi-asserted-by":"publisher","award":["8-9\/FDC\/RPS (NER)\/POLICY-1\/2020\\u201321"],"award-info":[{"award-number":["8-9\/FDC\/RPS (NER)\/POLICY-1\/2020\\u201321"]}],"id":[{"id":"10.13039\/501100001427","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021044","name":"Wisconsin Department of Public Instruction","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021044","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SR\/FST\/COLLEGE\/2021\/1172"],"award-info":[{"award-number":["SR\/FST\/COLLEGE\/2021\/1172"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DST \/NM\/ NB \/2018\/82"],"award-info":[{"award-number":["DST \/NM\/ NB \/2018\/82"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020075","name":"Corporaci\u00f3n Universitaria Remington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.pupt.2025.102361","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:48:35Z","timestamp":1748918915000},"page":"102361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development of Dry Powder Inhaler formulation for site specific delivery of nanoconjugates loaded with Curcumin and BCL2 siRNA in Lung Cancer"],"prefix":"10.1016","volume":"90","author":[{"given":"Madhuchandra","family":"Lahan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trideep","family":"Saikia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinku","family":"Baishya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alakesh","family":"Bharali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunayana","family":"Baruah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shatabdi","family":"Ghose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damiki","family":"Laloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhash","family":"Medhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8036-6496","authenticated-orcid":false,"given":"Bhanu P","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2025.102361_bib1","year":"2022","journal-title":"Lung cancer statistics"},{"key":"10.1016\/j.pupt.2025.102361_bib3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.apsb.2018.03.004","article-title":"Inhalation treatment of primary lung cancer using liposomal curcumin dry powder inhalers","volume":"8","author":"Zhang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.pupt.2025.102361_bib4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2174\/187152009787313828","article-title":"Importance and limitations of chemotherapy among the available treatments for gastrointestinal tumours","volume":"9","author":"Marin","year":"2009","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.pupt.2025.102361_bib5","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.52711\/0974-360X.2022.00469","article-title":"Pharmacological activities of curcumin: an update","volume":"15","author":"Alabdali","year":"2022","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.pupt.2025.102361_bib6","article-title":"Curcumin - pharmacological actions and its role in oral submucous fibrosis: a review","volume":"9","author":"Alok","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.pupt.2025.102361_bib7","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3892\/etm.2015.2749","article-title":"Biological and therapeutic activities, and anticancer properties of curcumin","volume":"10","author":"Perrone","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.pupt.2025.102361_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/antibiotics11020135","article-title":"Curcumin: biological activities and modern pharmaceutical forms","volume":"11","author":"Uro\u0161evi\u0107","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.pupt.2025.102361_bib9","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1080\/10942912.2022.2082464","article-title":"A review on selected pharmacological activities of Curcuma longa L","volume":"25","author":"Jyotirmayee","year":"2022","journal-title":"Int. J. Food Prop."},{"key":"10.1016\/j.pupt.2025.102361_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71129-0","article-title":"Drug-encapsulated blend of PLGA-PEG microspheres: in vitro and in vivo study of the effects of localized\/targeted drug delivery on the treatment of triple-negative breast cancer","volume":"10","author":"Jusu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pupt.2025.102361_bib11","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3389\/fphar.2018.01260","article-title":"PLGA-based nanoparticles in cancer treatment","volume":"9","author":"Rezvantalab","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pupt.2025.102361_bib12","doi-asserted-by":"crossref","first-page":"12962","DOI":"10.1073\/pnas.0504274102","article-title":"Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide","volume":"102","author":"Dharap","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.pupt.2025.102361_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111035","article-title":"LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer","volume":"114","author":"Shitole","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.pupt.2025.102361_bib14","first-page":"743","article-title":"Multifunctional approach with LHRH-mediated PLGA nanoconjugate for site-specific codelivery of curcumin and BCL2 siRNA in mice lung cancer","volume":"10","author":"Lahan","year":"2024","journal-title":"Future J. Pharm. Sci."},{"key":"10.1016\/j.pupt.2025.102361_bib15","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3390\/pharmaceutics14091974","article-title":"A review of non-invasive drug delivery through respiratory routes","volume":"14","author":"Zhang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pupt.2025.102361_bib16","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jconrel.2015.07.024","article-title":"Nanotechnology approaches for inhalation treatment of lung diseases","volume":"219","author":"Kuzmov","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.pupt.2025.102361_bib17","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3390\/pharmaceutics13071056","article-title":"Pulmonary drug delivery of antimicrobials and anticancer drugs using solid dispersions","volume":"13","author":"Al-Obaidi","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pupt.2025.102361_bib18","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/pharmaceutics12111025","article-title":"Pulmonary delivery of biological drugs","volume":"12","author":"Liang","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pupt.2025.102361_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3390\/pharmaceutics15010139","article-title":"Inhalable formulations to treat non-small cell lung cancer (NSCLC): recent therapies and developments","volume":"15","author":"Gupta","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pupt.2025.102361_bib20","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1038\/s41598-018-25930-7","article-title":"PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer","volume":"8","author":"Risnayanti","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pupt.2025.102361_bib21","article-title":"Systematic development and characterization of inhalable dry powder containing Polymeric Lipid Hybrid Nanocarriers co-loaded with ABCB1 shRNA and docetaxel using QbD approach","volume":"60","author":"Bardoliwala","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.pupt.2025.102361_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121736","article-title":"Mixing of dry powders for inhalation: a review","volume":"619","author":"Spahn","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.pupt.2025.102361_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7324\/JAPS.2018.8916","article-title":"Liquid chromatography and fourier transform infrared spectroscopy for quantitative analysis of individual and total curcuminoid in Curcuma longa extract","volume":"8","author":"Wulandari","year":"2018","journal-title":"J. Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.pupt.2025.102361_bib24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3390\/pharmaceutics14020407","article-title":"PEGylated chitosan nanoparticles encapsulating ascorbic acid and oxaliplatin exhibit dramatic apoptotic effects against breast cancer cells","volume":"14","author":"Fahmy","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pupt.2025.102361_bib25","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.3390\/pharmaceutics14061160","article-title":"The effect of encapsulated apigenin nanoparticles on HePG-2 cells through regulation of P53","volume":"14","author":"Mabrouk","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pupt.2025.102361_bib26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/pca.1129","article-title":"A simple isocratic HPLC method for the simultaneous determination of curcuminoids in commercial turmeric extracts","volume":"20","author":"Wichitnithad","year":"2009","journal-title":"Phytochem. Anal."},{"issue":"1","key":"10.1016\/j.pupt.2025.102361_bib27","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1038\/s41598-018-25930-7","article-title":"PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer","volume":"8","author":"Risnayanti","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.pupt.2025.102361_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpharm.2009.10.023","article-title":"Preparation and characterization of poly (DL-lactide-co-glycolide) nanoparticles for siRNA delivery","volume":"390","author":"Cun","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.pupt.2025.102361_bib29","article-title":"Fabrication and application of dimyristoyl phosphatidylcholine biomaterial-based nanocochleates dry powder inhaler for controlled release resveratrol delivery","volume":"7","author":"Mali","year":"2021","journal-title":"Future J Pharm Sci"},{"key":"10.1016\/j.pupt.2025.102361_bib30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: an add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.pupt.2025.102361_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2015.10.024","article-title":"siRNA-lipid nanoparticles with long-term storage stability facilitate potent gene-silencing in vivo","volume":"220","author":"Suzuki","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.pupt.2025.102361_bib32","article-title":"Stability, intracellular delivery, and release of siRNA from chitosan nanoparticles using different cross-linkers","volume":"10","author":"Raja","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2025.102361_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130783","article-title":"Optimizing long-term stability of siRNA using thermoassemble ionizable reverse pluronic-Bcl2 micelleplexes","volume":"264","author":"De","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.pupt.2025.102361_bib34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2015.10.024","article-title":"siRNA-lipid nanoparticles with long-term storage stability facilitate potent gene-silencing in vivo","volume":"220","author":"Suzuki","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.pupt.2025.102361_bib35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/IJN.S123062","article-title":"Achieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilization","volume":"12","author":"Ball","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.pupt.2025.102361_bib36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ijpharm.2011.11.040","article-title":"Stability of lyophilized siRNA nanosome formulations","volume":"423","author":"Kundu","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.pupt.2025.102361_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130783","article-title":"Optimizing long-term stability of siRNA using thermoassemble ionizable reverse pluronic-Bcl2 micelleplexes","volume":"264","author":"De","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.pupt.2025.102361_bib38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijpharm.2016.01.066","article-title":"Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate","volume":"501","author":"Simon","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.pupt.2025.102361_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190976","article-title":"Development and evaluation of chitosan nanoparticles based dry powder inhalation formulations of prothionamide","volume":"13","author":"Debnath","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2025.102361_bib40","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1080\/02786820903134143","article-title":"Size distributions of 0.5 to 20 \u03bcm aerodynamic diameter lead-containing particles from aerosol sampler walls and filters","volume":"43","author":"Lee","year":"2009","journal-title":"Aerosol Sci. Technol."},{"key":"10.1016\/j.pupt.2025.102361_bib41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/ddc3010016","article-title":"Development of paclitaxel proliposomal dry powder inhaler (PTX-PLM-DPI) by freeze-drying method for lung cancer","volume":"3","author":"Borah","year":"2024","journal-title":"Drugs Drug Candidates"},{"key":"10.1016\/j.pupt.2025.102361_bib42","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.2147\/IJN.S306831","article-title":"Design and characterization of spray-dried proliposomes for the pulmonary delivery of curcumin","volume":"16","author":"Adel","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.pupt.2025.102361_bib43","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s11095-010-0329-x","article-title":"Temozolomide-based dry powder formulations for lung tumor-related inhalation treatment","volume":"28","author":"Wauthoz","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.pupt.2025.102361_bib44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejpb.2021.04.018","article-title":"The combination of an innovative dry powder for inhalation and a standard cisplatin-based chemotherapy in view of therapeutic intensification against lung tumours","volume":"164","author":"Chraibi","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.pupt.2025.102361_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109330","article-title":"Immunosuppressive role of benzo[a]pyrene in induction of lung cancer in mice","volume":"333","author":"Salem","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.pupt.2025.102361_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/678218","article-title":"Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s)","author":"Gutierres","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.pupt.2025.102361_bib47","first-page":"179","article-title":"A pharmacokinetic study of diclofenac sodium in rats","volume":"7","author":"Yuan","year":"2017","journal-title":"Biomed Rep"},{"key":"10.1016\/j.pupt.2025.102361_bib48","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/ph16121658","article-title":"Inhalation dosage forms: a focus on dry powder inhalers and their advancements","volume":"16","author":"Magramane","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.pupt.2025.102361_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pupt.2025.102361_bib50","doi-asserted-by":"crossref","first-page":"7186","DOI":"10.1039\/C5TB01377A","article-title":"Gene silencing of the pro-inflammatory cytokine TNF-\u03b1 with siRNA delivered by calcium phosphate nanoparticles, quantified by different methods","volume":"3","author":"Neuhaus","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.pupt.2025.102361_bib51","first-page":"2591","article-title":"Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells","volume":"6","author":"Mura","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.pupt.2025.102361_bib52","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/adma.201201800","article-title":"Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery","volume":"24","author":"Ensign","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.pupt.2025.102361_bib53","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3390\/pharmaceutics13070974","article-title":"Dual-acting zeta-potential-changing micelles for optimal mucus diffusion and enhanced cellular uptake after oral delivery","volume":"13","author":"Malkawi","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pupt.2025.102361_bib54","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.pupt.2025.102361_bib55","doi-asserted-by":"crossref","first-page":"25518","DOI":"10.1039\/C5RA00018A","article-title":"Curcumin entrapped folic acid conjugated PLGA\u2013PEG nanoparticles exhibit enhanced anticancer activity by site specific delivery","volume":"5","author":"Pillai","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.pupt.2025.102361_bib56","first-page":"226","article-title":"Polymeric nanoparticles in cancer chemotherapy: a narrative review","volume":"51","author":"Yousefi Rizi","year":"2022","journal-title":"Iran. J. Public Health"},{"key":"10.1016\/j.pupt.2025.102361_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087326","article-title":"Design and optimization of PLGA-based diclofenac loaded nanoparticles","volume":"9","author":"Cooper","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2025.102361_bib58","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3390\/ma16031212","article-title":"Freeze drying of polymer nanoparticles and liposomes exploiting different saccharide-based approaches","volume":"16","author":"Andreana","year":"2023","journal-title":"Mater"},{"key":"10.1016\/j.pupt.2025.102361_bib59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2016.05.052","article-title":"Influence of mannitol concentration on the physicochemical, mechanical and pharmaceutical properties of lyophilised mannitol","volume":"510","author":"Kaialy","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.pupt.2025.102361_bib60","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2014.05.058","article-title":"Controlled delivery of inhaled therapeutic agents","volume":"190","author":"Hickey","year":"2014","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.pupt.2025.102361_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120244","article-title":"Understanding flow properties of mannitol powder at a range of temperature and humidity","volume":"596","author":"Salehi","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.pupt.2025.102361_bib63","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1088\/0143-0815\/7\/2\/004","article-title":"Droplet size distributions of nebulised aerosols for inhalation therapy","volume":"7","author":"Newman","year":"1986","journal-title":"Clin. Phys. Physiol. Meas."},{"key":"10.1016\/j.pupt.2025.102361_bib64","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1152\/jappl.1998.85.2.379","article-title":"Recent advances in pulmonary drug delivery using large, porous inhaled particles","volume":"85","author":"Edwards","year":"1998","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.pupt.2025.102361_bib65","first-page":"1868","article-title":"Large porous particles for pulmonary drug delivery","volume":"276","author":"Edwards","year":"1997","journal-title":"Sci. Technol. Humanit."},{"key":"10.1016\/j.pupt.2025.102361_bib66","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1021\/acsbiomaterials.9b00947","article-title":"Development and evaluation of paclitaxel-loaded aerosol nanocomposite microparticles and their efficacy against air-grown lung cancer tumor spheroids","volume":"5","author":"Guzm\u00e1n","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.pupt.2025.102361_bib67","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0021-8502(86)90035-2","article-title":"Deposition of particles in the human respiratory tract in the size range 0.005\u201315 \u03bcm","volume":"17","author":"Heyder","year":"1986","journal-title":"J. Aerosol Sci."},{"key":"10.1016\/j.pupt.2025.102361_bib68","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.drudis.2018.01.016","article-title":"Pharmaceutical nanocrystals: production by wet milling and applications","volume":"23","author":"Malamatari","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.pupt.2025.102361_bib69","article-title":"Intratracheal administration of dry powder formulation in mice","volume":"161","author":"Qiu","year":"2020","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.pupt.2025.102361_bib70","first-page":"1","article-title":"NTP Toxicology and carcinogenesis studies of turmeric oleoresin (CAS No. 8024-37-1) (major component 79%-85% curcumin, CAS No. 458-37-7) in F344\/N rats and B6C3F1 mice (feed studies), natl. Toxicol","volume":"427","year":"1993","journal-title":"Program Tech. Rep. Ser."},{"key":"10.1016\/j.pupt.2025.102361_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2019.01.010","article-title":"Curcumin, the golden spice in treating cardiovascular diseases","volume":"38","author":"Li","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.pupt.2025.102361_bib72","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00210-021-02072-8","article-title":"Protective effects of curcumin on chemical and drug-induced cardiotoxicity: a review","volume":"394","author":"Yarmohammadi","year":"2021","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pupt.2025.102361_bib73","doi-asserted-by":"crossref","DOI":"10.1186\/s11671-015-1085-y","article-title":"Evaluation of high-performance curcumin nanocrystals for pulmonary drug delivery both in vitro and in vivo","volume":"10","author":"Hu","year":"2015","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.pupt.2025.102361_bib74","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/bph.12131","article-title":"Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers","volume":"169","author":"Aggarwal","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pupt.2025.102361_bib75","doi-asserted-by":"crossref","first-page":"50747","DOI":"10.18632\/oncotarget.17096","article-title":"Curcumin induces G2\/M cell cycle arrest and apoptosis of head and neck squamous cell carcinoma in vitro and in vivo through ATM\/Chk2\/p53-dependent pathway","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pupt.2025.102361_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101320","article-title":"Curcumin stabilizes p53 by interaction with NAD(P)Hoxidoreductase 1 in tumor-derived cell lines","volume":"28","author":"Pati\u00f1o-Morales","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.pupt.2025.102361_bib77","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tips.2008.11.002","article-title":"Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets","volume":"30","author":"Aggarwal","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pupt.2025.102361_bib78","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nbt1081","article-title":"Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA","volume":"23","author":"Judge","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pupt.2025.102361_bib79","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s13346-010-0008-9","article-title":"Nanoparticle-mediated p53 gene therapy for tumor inhibition","volume":"1","author":"Sharma","year":"2011","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.pupt.2025.102361_bib80","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cytogfr.2015.12.004","article-title":"Molecular mechanisms of curcumin's suppressing effects on tumorigenesis, angiogenesis and metastasis, focusing on NF-\u03baB pathway","volume":"28","author":"Panahi","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.pupt.2025.102361_bib81","article-title":"Curcumin stabilizes p53 by interaction with NAD(P)H:Quinone oxidoreductase 1 in tumor-derived cell lines","volume":"28","author":"Pati\u00f1o-Morales","year":"2019","journal-title":"Redox Biol."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553925000185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553925000185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:41:14Z","timestamp":1762364474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553925000185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":79,"alternative-id":["S1094553925000185"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2025.102361","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of Dry Powder Inhaler formulation for site specific delivery of nanoconjugates loaded with Curcumin and BCL2 siRNA in Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2025.102361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102361"}}